Marker Therapeutics Inc.

06/09/2025 | Press release | Distributed by Public on 06/09/2025 14:14

Proxy Results (Form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 6, 2025, the Company held its 2025 Annual Meeting of Stockholders (the "Annual Meeting"). The stockholders considered three proposals, each of which is described in more detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 24, 2025. Of the 11,314,835 shares outstanding as of the record date, 7,629,048 shares, or 67.43%, were present virtually or represented by proxy at the Annual Meeting. Set forth below are the results of the matters submitted for a vote of stockholders at the Annual Meeting.

Proposal No. 1: Election of four nominees to serve as directors until the 2026 annual meeting of stockholders and until their respective successors are elected and qualified. The votes were cast as follows:

Name Votes For Votes
Withheld
David Eansor 4,095,249 711,872
Steven Elms 4,094,745 712,376
Katharine Knobil 4,079,812 727,309
Juan Vera 4,143,496 663,625

Broker Non-Votes: 2,821,927.

All nominees were elected.

Proposal No. 2: Approval, on an advisory basis, of the compensation of the Company's named executive officers. The votes were cast as follows:

Votes For Votes
Against
Abstained
Advisory approval of named executive officer compensation 4,449,829 343,434 13,857

Broker Non-Votes: 2,821,927.

Proposal No. 3: Ratification of the selection of Marcum LLP as independent registered public accounting firm for the fiscal year ending December 31, 2025. The votes were cast as follows:

Votes For Votes
Against
Abstained
Ratification of appointment of Marcum LLP 7,494,386 80,755 53,907

Broker Non-Votes: 0.

Marker Therapeutics Inc. published this content on June 09, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on June 09, 2025 at 20:14 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io